Ribacee
Capsule
Generic Name
Ribavirin
Manufacturer
Jenphar Bangladesh Ltd.
Unit Price
Unit Price: ৳ 35.00 (3 x 10: ৳ 1,050.00) Strip Price: ৳ 350.00
🔹 Indications
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Ribacee as monotherapy is not effective and Ribacee must not be used alone.
🔹 Pharmacology
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Ribacee as monotherapy is not effective and Ribacee must not be used alone.
🔹 Dosage & Administration
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Ribacee as monotherapy is not effective and Ribacee must not be used alone.
🔹 Interaction
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Ribacee as monotherapy is not effective and Ribacee must not be used alone.
🔹 Contraindications
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Ribacee as monotherapy is not effective and Ribacee must not be used alone.
🔹 Side Effects
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Ribacee as monotherapy is not effective and Ribacee must not be used alone.
🔹 Pregnancy & Lactation
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Ribacee as monotherapy is not effective and Ribacee must not be used alone.
🔹 Precautions & Warnings
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously treated with interferon alpha. Ribacee as monotherapy is not effective and Ribacee must not be used alone.
🔍 People also search for
💡 Frequently Asked Questions
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously trea...
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously trea...
Ribacee in combination with Peginterferon alfa-2a or Interferon alfa is indicated for the treatment of patients 5 years of age and older with chronic hepatitis C (CHC) virus infection who have compensated liver disease and have not be previously trea...
User Reviews
⭐
No reviews yet!
Be the first to share your experience.